FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Spread Awareness

Learn more about ALS and help others do the same. Download and share this information to create understanding and generate support for people living with ALS.

Facebook

Instagram

LinkedIn

X (formerly Twitter)